Corient Capital Partners, LLC Incyte Corp Transaction History
Corient Capital Partners, LLC
- $1.34 Billion
- Q3 2022
A detailed history of Corient Capital Partners, LLC transactions in Incyte Corp stock. As of the latest transaction made, Corient Capital Partners, LLC holds 3,486 shares of INCY stock, worth $247,680. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,486
Previous 3,481
0.14%
Holding current value
$247,680
Previous $265,000
-0.0%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding INCY
# of Institutions
642Shares Held
186MCall Options Held
714KPut Options Held
557K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.18 Billion21.76% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.52 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.45 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA15.3MShares$1.09 Billion0.61% of portfolio
-
State Street Corp Boston, MA10.6MShares$750 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $15.8B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...